Risk factors of sudden cardiac death in patients with hypertrophic cardiomyopathy

V.I. Tseluiko, O.O. Butko

References 

1. Целуйко В.И., Ковалевская О.С. Гипертрофическая кардиомиопатия: методическое пособие в таблицах и схемах.– Х.: Гриф, 1999.– 204 с.
2. Elliott P., Spirito P.Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice // Heart.– 2008.– N 94.– Р. 1269–1275.
3. Elliott P.M., Gimeno Blanes J.R., Mahon N.G. et al. Relation between severity of leftventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy // Lancet.– 2001.– N 357.– Р. 420–424.
4. Elliott P.M., Gimeno J.R., Tome M.T. et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy // Eur Heart J.– 2006.– N 27.– Р. 1933–1941.
5. Hughes S.E. The pathology of hypertrophic cardiomyopathy // Histopathology.– 2004.– N 44.– Р. 412–427.
6. Maron B.J., McKenna W.J., Danielson G.K. et al. Clinical expert consensus document on hypertrophic cardiomyopathy ACC/ESC // Eur. Heart. J.– 2003.– Vol. 24.– P. 1965–1991.
7. Maron B.J., Pelliccia A. The heart of trained athletes cardiac remodeling and the risks of sports, including sudden death // Circulation.– 2006.– N 114.– Р. 1633–1644.
8. Maron B.J., Spirito P., Shen W.K. et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy // JAMA.– 2007.– N 298 (4).– Р. 405–412.
9. Ostman-Smith I., Wettrell G., Keeton B. et al. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy // Eur. Heart J.– 2008.– N 29.– Р. 1160–1167.
10. Spirito P., Bellone P., Harris K.M. et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy // New Engl. J. Med.– 2000.– N 342.– Р. 1778–1785.
11. Tsoutsman T., Lam L., Semsarian C. Genes, calcium and modifying factors in hypertrophic cardiomyopathy // Clin. Exp. Pharmacol. Physiol.– 2006.– N 33.– Р. 139–145.
12. Woo A., Monakier D., Harris L. et al. Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy // Heart.– 2007.– N 93.– Р. 1044–1045.